Abstract
Using high-resolution array-CGH, we identified unique duplications of a region on 6q27 in four multiplex families with at least three cases of chordoma, a cancer of presumed notochordal origin. The duplicated region contains only the T (brachyury) gene, which is important in notochord development and is expressed in most sporadic chordomas. Our findings highlight the value of screening for complex genomic rearrangements in searches for cancer-susceptibility genes.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

Accession codes
References
McCarroll, S.A. & Altshuler, D.M. Nat. Genet. 39, S37–S42 (2007).
Inoue, K. & Lupski, J.R. Annu. Rev. Genomics Hum. Genet. 3, 199–242 (2002).
Lupski, J.R. Nat. Genet. 39, S43–S47 (2007).
Padiath, Q.S. et al. Nat. Genet. 38, 1114–1123 (2006).
Le Maréchal, M.C. et al. Nat. Genet. 38, 1372–1374 (2006).
Lee, J.A. & Lupski, J.R. Neuron 52, 103–121 (2006).
Malawer, MM, Link, MP & Donaldson, SS in Sarcomas of Bone (eds. Devita, V.T., Hellman, S. & Rosenberg, S.A.) 844–1846 (Lippincott-Raven, Philadelphia, 1997).
Kelley, M.J. et al. Am. J. Hum. Genet. 69, 454–460 (2001).
Yang, X.R. et al. Int. J. Cancer 116, 487–491 (2005).
Kispert, A., Koschorz, B. & Herrmann, B.G. EMBO J. 14, 4763–4772 (1995).
Kispert, A. & Herrmann, B.G. Dev. Biol. 161, 179–193 (1994).
Vujovic, S. et al. J. Pathol. 209, 157–165 (2006).
Chanda, B. et al. Hum. Mol. Genet. 17, 3446–3458 (2008).
Acknowledgements
We thank D. Zametkin for her outstanding skills as a research nurse; G.M. Glenn and M.L. McMaster for their careful clinical evaluations of affected individuals and family members; N.J. Patronas for reviewing the MRIs; A. Bergen and S. Chanock for SNP genotyping; K. Haque and D. Maeder for technical assistance; and, especially, the affected individuals and their families for their participation. This work was supported by the intramural research program of the US National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Institutes of Health; by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development program; and by a grant from the Chordoma Foundation (M.J.K.).
Author information
Authors and Affiliations
Contributions
X.R.Y. wrote the first draft of the paper; X.R.Y. and D.N. analyzed the data; D.N., S.L., M.J.K. and D.A.A. performed the laboratory studies, including genotyping, sequencing and breakpoint evaluation; D.N. designed and conducted qPCR analyses; D.M.P. initiated the clinical study and evaluated the chordoma-affected families with D.N.; D.M.P., E.S. and N.J.L. collected the families; X.R.Y., D.N., M.J.K., D.M.P. and A.M.G. planned the work and interpreted the results. All authors contributed to the final version of the paper.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Tables 1 and 2 and Supplementary Figures 1–3 (PDF 2096 kb)
Rights and permissions
About this article
Cite this article
Yang, X., Ng, D., Alcorta, D. et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet 41, 1176–1178 (2009). https://doi.org/10.1038/ng.454
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.454
Further reading
-
Inducing substances for chondrogenic differentiation of dental pulp stem cells in the conditioned medium of a novel chordoma cell line
Human Cell (2022)
-
Multiple malignant tumors in a patient with familial chordoma, a case report
BMC Medical Genomics (2021)
-
Molecular features and vulnerabilities of recurrent chordomas
Journal of Experimental & Clinical Cancer Research (2021)
-
Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy
Targeted Oncology (2021)
-
Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival
Nature Communications (2021)